Logo

Pressure BioSciences Sells First Bench Top Sample-Prep System to FDA

Nov 15, 2005

NEW YORK, Nov. 15 (GenomeWeb News) - Pressure BioSciences sold its first bench-top PCT sample-preparation system to the US Food and Drug Administration, the company said today.

 

The company also signed a one-year lease with the University of New Hampshire and a three-month lease with a midwestern biotech firm for the system.

 

The FDA is expected to use the system to extract proteins from bacteria, to process food to detect allergen contamination, and to evaluate dietary supplements, Pressure said.

 

The University of New Hampshire and the biotech company are expected to use the system to process biological samples to study DNA, RNA, and proteins.

 

Additional details were not disclosed.

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.